(Sharecast News) - The Beauty Tech Group rallied on Thursday as it lifted its full-year profit outlook, posted a jump in first-half profit and revenue and hailed a better-than-expected performance across all key metrics amid solid demand for at-home beauty technology.

In the six months to the end of June, adjusted pre-tax profit rose 49% to £15.3m, with revenue up 44.3% at £79.7m. Adjusted earnings before interest, tax, depreciation and amortisation grew 53% to £21.3m and the adjusted EBITDA margin improved to 26.7% from 25.2% in the same period a year earlier.

Beauty Tech said growth was driven by the LED range within CurrentBody Skin, across anti-ageing and hair regrowth, and across multiple geographies. Germany was the largest contributor in continental Europe, with Poland, Spain and the Netherlands also advancing. Australia and the Middle East grew strongly from smaller bases, it said.

The company said it remains confident in delivering full-year revenue in line with the upgraded guidance of no less than £170m announced in July. However, with the strong adjusted EBITDA margin expansion in the first half and increasing confidence in delivering on a typically stronger margin profile in the second half, full-year year adjusted EBITDA is now expected to be no less than £48.5m, up from previous guidance of no less than £45m.

Beauty Tech also said on Thursday that it plans to launch a £20m share buyback in the next four weeks.

Founder and chief executive Laurence Newman said: "At-home beauty technology is the fastest-growing part of the beauty market and we are uniquely positioned to take advantage of it through our three distinct brands: CurrentBody Skin, ZIIP Beauty and Tria Laser.

"In parallel with our considerable growth rate, our business has continued to go from strength to strength. We have entered the second half, typically our strongest period of trading, with real momentum and a significant launch pipeline, and as a result I remain confident in the outlook for the year."

At 0935 BST, the shares were up 11.4% at 390p.

See latest RNS on Investegate